Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Bull Exp Biol Med ; 148(3): 511-3, 2009 Sep.
Article in English, Russian | MEDLINE | ID: mdl-20396726

ABSTRACT

Modeling of NO deficiency by administration of L-NAME to rats led to the development of arterial hypertension and endothelial dysfunction. Pronounced endothelium and cardioprotective effects of impaza under these experimental conditions manifested more markedly during combined administration of the preparation with standard hypotensive preparations enalapril and losartan.


Subject(s)
Antibodies/therapeutic use , Enalapril/therapeutic use , Hypertension/drug therapy , Losartan/therapeutic use , Nitric Oxide/deficiency , Animals , Hypertension/chemically induced , Male , NG-Nitroarginine Methyl Ester/pharmacology , Rats , Rats, Wistar
2.
Bull Exp Biol Med ; 148(3): 514-7, 2009 Sep.
Article in English, Russian | MEDLINE | ID: mdl-20396727

ABSTRACT

Experimental NO deficiency induced by L-NAME injection led to the development of arterial hypertension, endothelial dysfunction, and cardiomyocyte hypertrophy and reduced blood content of nitrates and nitrites. Impaza, NO donors, activators of NO-synthase, antioxidants, and antihypertensive preparations produced endothelium-protective effect of different degree.


Subject(s)
Antibodies/therapeutic use , Endothelium, Vascular/drug effects , Nitric Oxide/deficiency , Animals , Antihypertensive Agents/therapeutic use , Antioxidants/therapeutic use , Hypertension/chemically induced , Hypertension/drug therapy , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitrates/metabolism , Nitric Oxide Donors/therapeutic use , Nitrites/metabolism , Rats , Rats, Wistar , Resveratrol , Stilbenes/therapeutic use
3.
Eksp Klin Farmakol ; 71(3): 23-5, 2008.
Article in Russian | MEDLINE | ID: mdl-18652251

ABSTRACT

In tests on a group of 250 rats, we studied (i) the level of microcirculation in the muscles of a healthy limb in the norm and (ii) the dynamics of microcirculation for 6 h after treatment with pentoxifylline in a dose of 60 mg/kg dose and L-arginine in a dose of 30 and 200 mg/kg. The chronic ischemia was modeled by excision of basic femoral artery. There was no significant difference in pentoxyfilline-treated animals in comparison to the control. In the group treated with L-arginine in a dose of 30 mg/kg, a significant increase in microcirculation was observed on the 28-th day of experiment. In the group treated with L-arginine in a dose of 200 mg/kg, there was an increase of microcirculation in all terms of the experiment in comparison to the control. The results of laser doppler flow measurements are correlated with the results of morphological investigation.


Subject(s)
Arginine/therapeutic use , Hindlimb/blood supply , Ischemia/drug therapy , Muscle, Skeletal/blood supply , Pentoxifylline/therapeutic use , Vasodilator Agents/therapeutic use , Animals , Female , Ischemia/physiopathology , Laser-Doppler Flowmetry , Microcirculation , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Rats, Wistar , Regional Blood Flow
4.
Bull Exp Biol Med ; 143(6): 678-81, 2007 Jun.
Article in English, Russian | MEDLINE | ID: mdl-18239799

ABSTRACT

We studied the effects of antioxidants resveratrol and pQ510 on physiological parameters and the state of endothelial NO-synthase as a marker of the regulatory function of the endothelium in the aorta of rats with modeled arterial hypertension. The antioxidants promoted recovery of stable NO metabolites in rat serum and maintained expression of endothelial NO-synthase at a normal level. These effects were confirmed by correction of blood pressure and endothelium-dependent vascular dilation assessed by endothelial dysfunction coefficient.


Subject(s)
Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Endothelium, Vascular/drug effects , Organometallic Compounds/pharmacology , Stilbenes/pharmacology , Animals , Endothelium, Vascular/physiology , Hypertension/chemically induced , Male , NG-Nitroarginine Methyl Ester , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type III , Rats , Rats, Wistar , Resveratrol
5.
Farmakol Toksikol ; 52(5): 17-9, 1989.
Article in Russian | MEDLINE | ID: mdl-2599070

ABSTRACT

Intracoronary administration of emoxypine caused the dose-dependent increase in the average coronary blood flow without changing the parameters of cardiohemodynamics. Emoxypine failed to change the structure of the phase coronary blood flow. When administered at the concentration of 5.10(-4)M emoxypine increased the volume rate of the perfusate outflow from the rat isolated heart cavities and decreased the value of potassium contracture of isolated segments of the coronary vessels. The data obtained indicate the direct coronarolytic action of emoxypine.


Subject(s)
Antioxidants/pharmacology , Coronary Vessels/drug effects , Picolines/pharmacology , Vascular Resistance/drug effects , Animals , Coronary Circulation/drug effects , Dogs , Dose-Response Relationship, Drug , In Vitro Techniques , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...